Rusan Pharma Achieves Global GMP Milestone with PMDA Japan Approval
Apr 20, 2026
Mumbai (Maharashtra) [India], April 20: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved a significant global regulatory milestone with the successful Good Manufacturing Practice (GMP) approvals from Japan's Pharmaceuticals and Medical Devices Agency (PMDA). This achievement reinforces the company's commitment to world-class quality, compliance, and global manufacturing excellence.